Cargando…
Influence of the practice setting on diagnostic prediction rules using FENO measurement in combination with clinical signs and symptoms of asthma
OBJECTIVES: To evaluate the influence of the practice setting on diagnostic accuracy of fractional exhaled nitric oxide (FENO) for diagnosing asthma; and to develop prediction rules for diagnostic decision-making including clinical signs and symptoms (CSS). SETTING: Patients from 10 general practice...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663408/ https://www.ncbi.nlm.nih.gov/pubmed/26603255 http://dx.doi.org/10.1136/bmjopen-2015-009676 |
_version_ | 1782403290365952000 |
---|---|
author | Schneider, Antonius Wagenpfeil, Gudrun Jörres, Rudolf A Wagenpfeil, Stefan |
author_facet | Schneider, Antonius Wagenpfeil, Gudrun Jörres, Rudolf A Wagenpfeil, Stefan |
author_sort | Schneider, Antonius |
collection | PubMed |
description | OBJECTIVES: To evaluate the influence of the practice setting on diagnostic accuracy of fractional exhaled nitric oxide (FENO) for diagnosing asthma; and to develop prediction rules for diagnostic decision-making including clinical signs and symptoms (CSS). SETTING: Patients from 10 general practices and 1 private practice of 5 pneumologists in ambulatory care. PARTICIPANTS: 553 patients, 57.9% female. Consecutive inclusion of diagnostic-naive patients suspected of suffering from obstructive airway disease. Exclusion criteria were respiratory tract infections within the last 6 weeks. INTERVENTIONS: The index test was FENO measurement. Reference standard was the Tiffeneau ratio (forced expiratory volume in 1 s/vital capacity) or airway resistance as assessed by whole body plethysmography, with additional bronchoprovocation or bronchodilator testing. PRIMARY AND SECONDARY OUTCOME MEASURES: Asthma as determined by pneumologists, who were blind to FENO measurement results. Prediction rules were derived from multiple logistic regression analysis. A freely available calculator that allows computing all combinations was developed. RESULTS: The practice setting only had minor influence on sensitivities of FENO cut-off points. In the final model (n=472), allergic rhinitis, wheezing and previous medication were positively associated with asthma. Increasing age and recurrent respiratory tract infections were negatively associated. The area under the curve (AUC) of FENO (AUC=0.650; 95% CI 0.599 to 0.701) increased significantly (p<0.0001) when combined with CSS (AUC=0.753; 95% CI 0.707 to 0.798). Presence of wheezing and allergic rhinitis allowed ruling in asthma with FENO >30 ppb. Ruling out with FENO <16 ppb in patients <43 years was only possible without allergic symptoms when recurrent respiratory tract infections were present. CONCLUSIONS: FENO results should be interpreted in the context of CSS to enhance their diagnostic value in primary care. The final diagnostic model appears as a sound algorithm fitting well to the established diagnostic rules related to CSS of asthma. FENO appears more effective for ruling in asthma than for ruling it out. |
format | Online Article Text |
id | pubmed-4663408 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-46634082015-12-03 Influence of the practice setting on diagnostic prediction rules using FENO measurement in combination with clinical signs and symptoms of asthma Schneider, Antonius Wagenpfeil, Gudrun Jörres, Rudolf A Wagenpfeil, Stefan BMJ Open Respiratory Medicine OBJECTIVES: To evaluate the influence of the practice setting on diagnostic accuracy of fractional exhaled nitric oxide (FENO) for diagnosing asthma; and to develop prediction rules for diagnostic decision-making including clinical signs and symptoms (CSS). SETTING: Patients from 10 general practices and 1 private practice of 5 pneumologists in ambulatory care. PARTICIPANTS: 553 patients, 57.9% female. Consecutive inclusion of diagnostic-naive patients suspected of suffering from obstructive airway disease. Exclusion criteria were respiratory tract infections within the last 6 weeks. INTERVENTIONS: The index test was FENO measurement. Reference standard was the Tiffeneau ratio (forced expiratory volume in 1 s/vital capacity) or airway resistance as assessed by whole body plethysmography, with additional bronchoprovocation or bronchodilator testing. PRIMARY AND SECONDARY OUTCOME MEASURES: Asthma as determined by pneumologists, who were blind to FENO measurement results. Prediction rules were derived from multiple logistic regression analysis. A freely available calculator that allows computing all combinations was developed. RESULTS: The practice setting only had minor influence on sensitivities of FENO cut-off points. In the final model (n=472), allergic rhinitis, wheezing and previous medication were positively associated with asthma. Increasing age and recurrent respiratory tract infections were negatively associated. The area under the curve (AUC) of FENO (AUC=0.650; 95% CI 0.599 to 0.701) increased significantly (p<0.0001) when combined with CSS (AUC=0.753; 95% CI 0.707 to 0.798). Presence of wheezing and allergic rhinitis allowed ruling in asthma with FENO >30 ppb. Ruling out with FENO <16 ppb in patients <43 years was only possible without allergic symptoms when recurrent respiratory tract infections were present. CONCLUSIONS: FENO results should be interpreted in the context of CSS to enhance their diagnostic value in primary care. The final diagnostic model appears as a sound algorithm fitting well to the established diagnostic rules related to CSS of asthma. FENO appears more effective for ruling in asthma than for ruling it out. BMJ Publishing Group 2015-11-24 /pmc/articles/PMC4663408/ /pubmed/26603255 http://dx.doi.org/10.1136/bmjopen-2015-009676 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Respiratory Medicine Schneider, Antonius Wagenpfeil, Gudrun Jörres, Rudolf A Wagenpfeil, Stefan Influence of the practice setting on diagnostic prediction rules using FENO measurement in combination with clinical signs and symptoms of asthma |
title | Influence of the practice setting on diagnostic prediction rules using FENO measurement in combination with clinical signs and symptoms of asthma |
title_full | Influence of the practice setting on diagnostic prediction rules using FENO measurement in combination with clinical signs and symptoms of asthma |
title_fullStr | Influence of the practice setting on diagnostic prediction rules using FENO measurement in combination with clinical signs and symptoms of asthma |
title_full_unstemmed | Influence of the practice setting on diagnostic prediction rules using FENO measurement in combination with clinical signs and symptoms of asthma |
title_short | Influence of the practice setting on diagnostic prediction rules using FENO measurement in combination with clinical signs and symptoms of asthma |
title_sort | influence of the practice setting on diagnostic prediction rules using feno measurement in combination with clinical signs and symptoms of asthma |
topic | Respiratory Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663408/ https://www.ncbi.nlm.nih.gov/pubmed/26603255 http://dx.doi.org/10.1136/bmjopen-2015-009676 |
work_keys_str_mv | AT schneiderantonius influenceofthepracticesettingondiagnosticpredictionrulesusingfenomeasurementincombinationwithclinicalsignsandsymptomsofasthma AT wagenpfeilgudrun influenceofthepracticesettingondiagnosticpredictionrulesusingfenomeasurementincombinationwithclinicalsignsandsymptomsofasthma AT jorresrudolfa influenceofthepracticesettingondiagnosticpredictionrulesusingfenomeasurementincombinationwithclinicalsignsandsymptomsofasthma AT wagenpfeilstefan influenceofthepracticesettingondiagnosticpredictionrulesusingfenomeasurementincombinationwithclinicalsignsandsymptomsofasthma |